Six different makes of continuous flush device were compared for reliability of flow rate and ease of use. All of the devices tested were considered suitable for flushing of vascular pressure monitoring catheters. However, flow rates were considered too variable for control of drug infusions or flushing of intracranial pressure monitoring systems.
Continuous flush devices were developed by Sorenson Research Company! to maintain catheter patency and to prevent clotting during direct vascular pressure monitoring. There is now a large number of devices commercially available and their use has been extended to control of drug infusions 2 and to flushing of intracranial pressure monitoring systems. 3 The working principle of all currently available devices is the same. They introduce a fixed resistance into a pressurized infusion . system such that a proximal pressure of 300 mmHg (40 kPa) will result in a distal flow of approximately 3 mllhour. Each device also incorporates some form of manually operated 'fast flush' mechanism. A common infusion system consists of a plastic 500 ml bag of infusion fluid connected by infusion tubing to the flushing device. The bag is pressurised by inflating an externally applied pressure infusor cuff. Hart et al. 4 have shown that only when a full 500 ml bag of infusion fluid is used will the pressure delivered to the flush device match the cuff pressure. Thereafter there will be an almost linear decrease in delivered pressure as the volume of the infusion bag falls, despite maintaining a constant cuff pressure. In this paper six currently available continuous flushing devices are compared with strict control of delivered pressure. Attention is paid not only to flow rate, but also to reliability, cost and ease of use.
MATERIALS AND METHOD The six makes tested are shown in Figure 1 . They are the Pharmaseal (AHS, California), the Steriflo (Cobe/Japan), the Critiflo (Gould, California), the Intraflo II (Sorenson Research, Utah), the Securiflo (Peter von Berg, Munich, Germany) and the Flushflo (Bentley Laboratories, California). Ten devices from each make were obtained from at least two different batches. Each device was assessed in 3 stages:
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Measurement of Flow Rate
The system used to measure flow rates is illustrated in Figure 2 . Three plastic 500 ml bags of 0.9% sodium chloride solution (Travenol, Australia) were pressurised by Medi-Quik Pressure Infusors (Terumo, Japan) maintained at 300 mmHg (40 kPa) by a Gairdner Hospital Automatic Pressure Regulator. 5 Two sets of infusion tubing were inserted into each bag. Five of these infusion tubing sets were then connected to individual continuous flushing devices. Each CFD emptied into a 50 ml collection jar via a 19 G needle. The collection jars were sealed to minimise evaporation but atmospheric pressure was ensured by maintaining a separate opening through a 26 G needle. The sixth infusion was connected to a Roche Kontron 144 pressure monitor using a Bentley, Trantec pressure transducer. The pressure displayed represented the pressure delivered to each continuous flushing device. The pressure in the infusor cuffs was also monitored by a second channel of the Roche Kontron 144. Both channels were calibrated against a mercury manometer. An MFE 2-channel chart recorder (MFE corporation, Salem, New Hampshire) was employed to record the pressure for the duration of each assessment. Using this system five devices could be assessed simultaneously while both infusor cuff pressure and delivered pressure were continuously monitored. The devices were assessed five at a time until all devices had been tested. Full 500 ml bags of saline were used for each assessment. The collection period was limited to 8 hours to minimise changes in delivered pressure related to decrease in infusion bag volume. 4 At the end of each 8-hour period the volume of the collection jar was measured in a 50 ml graduated cylinder. An hourly flow rate was calculated for each device, and a mean and standard deviation was calculated for each different make.
Measurement of 'Fast Flush' Rate
The same system was used. Using a stopwatch the fast flush mechanism was engaged for a 10 second period, while the delivered pressure was maintained at 300 mmHg. The volume flushed was measured in a graduated cylinder. The average of 3 measurements was taken for each device. A flow rate was then calculated for each device and a mean and standard deviation were calculated for each make.
Assessment of Ease of Use
Factors considered were the presence of Luer lock connections, the ease of detection of air bubbles, the incorporation of filters and the ease of engaging the fast flush mechanism. 
RESULTS
These are given in Table 1 . Mean flow rates ranged from 2.4 to 4.3 mllhour. Mean 'fast flush' rates ranged from 0.8 to 1.5 mllsecond. Variability of fast flush rates was considerably less than the variability of hourly flow rates.
DISCUSSION
Continuous flush devices are the most efficient and safe method of maintaining catheter patency during direct vascular pressure monitoring. 6 ,7 Although there are now many different devices commercially available, few have been subject to independent assessment. 7 Rithalia and Tinker evaluated six makes of flush devices in 1982.8 However, they did not specify that full 500 ml bags were used in their infusion systems. Moreover they only monitored infusor cuff pressure and not delivered pressure. It is interesting to note that the 'fast flush' rates they reported were consistently 30-500/0 less than those in the current study. This discrepancy could result if the volumes of their infusion bags were not maintained at 500 ml, leading to a fall in pressure delivered to the devices. 4 Fast flush rates are directly dependent on the pressure gradient across the device. In this study, rates were measured against atmospheric pressure and would be considerably less against arterial pressures. Continuous flow rates are far less dependent on distal pressures. l All devices are manufactured with proximal Luer and distal Luer lock connections which reduce the likelihood of disconnection. The Pharmaseal, Intraflo 11 and Flusflo incorporate 6-10 micron filters. The Pharmaseal is made of essentially opaque blue plastic and detection of trapped air bubbles is difficult. All other devices are manufactured with clear plastic.
The assessment of ease of engagement of 'fast flush' mechanism is to some extent subjective. Nevertheless, in general 'push' or 'pull' mechanisms were preferable to 'squeeze' mechanisms. It is imperative that the fast flush mechanism faithfully disengages when released, otherwise large volumes of fluid may be infused. The 'pull' mechanism of the Intraflo I occasionally failed to disengage. 9 This could be overcome if the valve was allowed to 'snap shut', rather than be slowly released. Similar problems have not been reported with the Intraflo 11. 'Push' mechanisms carry a risk of being accidentally or inadvertently engaged, particularly if they are strapped to a patient's arm or body. Care should be taken to avoid inadvertent engagement of fast flush mechanisms. Moreoever, it is important to check that the mechanism has disengaged when released. This can be done by observing the drip chamber of the infusion set.
The prices of the different makes are reasonably competitive (at the time of writing), but the differences may be significant when large numbers are used.
Overall the flow rates did not appear reliable enough for control of drug infusions and they cannot be recommended for this role. The use of continuous flushing devices in intracranial pressure monitoring systems is controversial and no recommendation for their use in this situation can be made without further evaluation. However, all the makes assessed in this study appeared to be suitable for flushing of vascular pressure monitoring catheters. Nevertheless, the use of any continuous flushing device demands an appreciation of the volume of fluid infused, especially in paediatric practice.
